Novartis AG (NYSE:NVS) is a Swiss pharmaceutical company that is one of the largest of its kind.
Keep Reading →
July 22 - News
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical leader focused on developing innovative treatments across oncology, immunology, neuroscience, cardiovascular, and renal diseases...
Keep Reading →
July 21 - News
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs.
Keep Reading →
July 19 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed what bank industry executives were saying about President Trump removing Federal Reserve Chairman Jerome...
Keep Reading →
July 18 - News
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics.
Keep Reading →
June 28 - News
US stocks don’t always lead. That’s the sentiment echoed across the equity markets as investors increasingly eschew US stocks in favor of international names.
Keep Reading →
June 28 - Hedge Funds, News
Novartis AG (NYSE:NVS) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds.
Keep Reading →
June 15 - News
Novartis AG (NYSE:NVS) is one of the 10 Undervalued European Stocks to Invest in Now. Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NYSE:NVS...
Keep Reading →
June 15 - News
On June 10, Carmine De Franco of BNP Paribas Asset Management appeared on CNBC to talk about the European market.
Keep Reading →
June 13 - Hedge Funds, News
Health and Human Services Secretary Robert F. Kennedy Jr.
Keep Reading →
June 13 - News
On March 5th, BBC reported that the US stock market had fallen after the tariffs sparked trade war fear.
Keep Reading →
March 4 - Hedge Funds, News
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development...
Keep Reading →
February 22 - Hedge Funds, News
The United States has long been a magnet for global businesses seeking to tap into its robust economy and dynamic financial markets.
Keep Reading →
February 20 - Hedge Funds, News
Dividends have historically been a key driver of investor returns, contributing 85% of the broader market's total return since 1960.
Keep Reading →
February 13 - Dividend Stocks, Hedge Funds, News
In 2025, dividends in MSCI Europe are expected to reach a record high.
Keep Reading →
February 10 - Dividend Stocks, Hedge Funds, News
In August, S&P Global Market Intelligence reported that US dividends are set to grow around 5.1% by the close of 2024.
Keep Reading →
February 5 - Dividend Stocks, Hedge Funds, News
Investing in healthcare equities is typically seen as protective during recessionary times.
Keep Reading →
December 28 - Hedge Funds, News
Dividend payouts for MSCI Europe companies hit a record €407 billion in 2023, and they are set to grow even more in 2024, with an expected increase to €433 billion, up about...
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News
'There are decades where nothing happens, and there are weeks where decades happen" is apt when starting a piece about global stocks.
Keep Reading →
December 16 - News
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools...
Keep Reading →
November 29 - Hedge Funds, News
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Keep Reading →
November 21 - News, Stock Analysis
In H2 of the year so far, there are signs that the S&P 500 index has been broadening beyond technology leadership and the index is reverting to a more normalized state.
Keep Reading →
October 1 - Hedge Funds, News
Jim Cramer often reflects on how he would reform the American education system if it were up to him.
Keep Reading →
September 4 - Hedge Funds, News
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate...
Keep Reading →
August 31 - Hedge Funds, Industries, News
The pharmaceutical industry is one of the most interesting sectors to invest in.
Keep Reading →
August 27 - News, Quantitative Investing
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
Keep Reading →
August 6 - Hedge Funds, Industries, News
As we move toward the second half of 2024, investors are eagerly preparing for the direction that the stock market will take for the remainder of the year.
Keep Reading →
June 11 - Dividend Stocks, Hedge Funds, News
As we move toward the second half of 2024, investors are eagerly preparing for the direction that the stock market will take for the remainder of the year.
Keep Reading →
June 11 - Dividend Stocks, Hedge Funds, News
In this article, we will take a look at the 11 oversold blue chip stocks to buy right now.
Keep Reading →
March 30 - Hedge Funds, News
In this article, we will be taking a look at the 5 most undervalued large-cap stocks to buy according to analysts.
Keep Reading →
March 24 - News
In this piece, we will take a look at the five most profitable biotech stocks to invest in.
Keep Reading →
March 14 - News, Quantitative Investing
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
In this article, we discuss 15 best annual dividend stocks to buy now.
Keep Reading →
January 30 - Dividend Stocks, Hedge Funds, News
In this article, we discuss 12 best foreign dividend stocks to invest in.
Keep Reading →
January 28 - Dividend Stocks, Hedge Funds, News
In this article, we will be taking a look at the 10 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - News
In this article, we shall discuss the 12 best diabetes stocks to buy now.
Keep Reading →
November 26 - Business, Hedge Funds, Industries, News
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we shall cover the top 10 oncology companies in the world.
Keep Reading →
October 13 - News
In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today.
Keep Reading →
August 21 - Hedge Funds, News
In this article, we will be taking a look at the 50 most valuable companies in the world by market cap.
Keep Reading →
July 27 - Lists, News
In this piece, we will take a look at the top 20 countries with the highest drug consumption.
Keep Reading →
June 21 - Lists, News
In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world.
Keep Reading →
June 13 - Lists, News
In this article, we will take a look at the 15 biggest immunotherapy companies in the world.
Keep Reading →
May 9 - Business, Lists, News
In this article, we will be taking a look at the 20 largest R&D companies in the world.
Keep Reading →
May 4 - Business, Lists, News
In this article, we take a look at 27 largest biotech companies in the US.
Keep Reading →
April 29 - Lists, News
One sector that has massively benefited from the advances in technology is healthcare.
Keep Reading →
April 4 - Hedge Funds, News
In this article, we will discuss the 12 Most Profitable Biotech Stocks Today.
Keep Reading →
March 3 - Business, News
In this article, we will take a look at the 22 most profitable stocks of the last 20 years.
Keep Reading →
February 27 - Hedge Funds, News
The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living.
Keep Reading →
February 22 - Lists, News